[1]
|
段远胜, 井超, 王旭东. 去泛素化酶PSMD14在肿瘤中的研究进展[J]. 中国肿瘤临床, 2022, 49(8): 407-410.
|
[2]
|
李兴爽, 王洋, 金一. 泛素-蛋白酶体系统研究进展[J]. 畜牧与兽医, 2016, 48(3): 137-141.
|
[3]
|
孙格格, 李新. 去泛素化酶与妇科恶性肿瘤相关研究进展[J]. 医学综述, 2022, 28(2): 265-270.
|
[4]
|
Komander, D., Clague, M.J. and Urbe, S. (2009) Breaking the Chains: Structureand Function of the Deubiquitinases. Nature Reviews Molecular Cell Biology, 10, 550-563. https://doi.org/10.1038/nrm2731
|
[5]
|
杨瑛, 泛素-蛋白酶体系在上皮性卵巢癌的差异性表达研究及阻断泛素-蛋白酶体途径促凋亡作用机制的初步分析[D]: [博士学位论文]. 成都: 四川大学, 2007.
|
[6]
|
俞纪东, 何松青. 泛素-蛋白酶体系统及蛋白酶体抑制剂在实体瘤治疗中作用的研究进展[J]. 中华实验外科杂志, 2017, 34(1): 174-176.
|
[7]
|
玛依拉·卡米力江, 哈丽丹·热依木, 阿丽叶古丽·艾皮热木, 等. 宫颈癌发生与血浆RelB和PSMD10蛋白质表达调控的关系及临床意义[J]. 医学研究杂志, 2017, 46(5): 28-31.
|
[8]
|
Guberman, M., Gang, H., Margulets, V., Jassal, D.S., Alagarsamy, K.N., Dhingra, S., Valenzuela Ripoll, C., Billia, F., Diwan, A., Javaheri, A. and Kirshenbaum, L.A. (2022) Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy. Circulation, 146, 934-954. https://doi.org/10.1161/CIRCULATIONAHA.121.058411
|
[9]
|
Harit, K., Bhattacharjee, R., Matuschewski, K., Becker, J., Kalinke, U., SchlÜTer, D. and Nishanth, G. (2023) the Deubiquitinating Enzyme OTUD7b Protects Dendritic Cells From TNF-Induced Apoptosis by Stabilizing the E3 Ligase TRAF2. Cell Death & Disease, 14, 480. https://doi.org/10.1038/s41419-023-06014-5
|
[10]
|
Dhingra, R., Rabinovich-Nikitin, I., Rothman, S., Guberman, M., Gang, H., Margulets, V., Jassal, D.S., Alagarsamy, K.N., Dhingra, S., Valenzuela Ripoll, C., Billia, F., Diwan, A., Javaheri, A. and Kirshenbaum, L.A. (2022) Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy. Circulation, 146, 934-954. https://doi.org/10.1161/CIRCULATIONAHA.121.058411
|
[11]
|
Liu, Y., Wu, M., Xu, S., Niu, X., Liu, W., Miao, C., Lin, A., Xu, Y. and Yu, L. (2023) PSMD2 Contributes To the Progression of Esophageal Squamous Cell Carcinoma by Repressing Autophagy. Cell & Bioscience, 13, 67. https://doi.org/10.1186/s13578-023-01016-4
|
[12]
|
Wang, S., Wang, H., Zhu, S. and Wang, Z. (2022) PSMD2 Promotes the Progression of Bladder Cancer and Is Correlated with Immune Infiltration. Frontiers in Oncology, 12, 1058506. https://doi.org/10.3389/fonc.2022.1058506
|
[13]
|
Salah Fararjeh, A., Al-Khader, A., Al-Saleem, M. and Abu Qauod, R. (2021) the Prognostic Significance of Proteasome 26S Subunit, Non-Atpase (PSMD) Genes for Bladder Urothelial Carcinoma Patients. Cancer Informatics, 20, 117693. https://doi.org/10.1177/11769351211067692
|
[14]
|
Matsuyama, Y., Suzuki, M., Arima, C., Huang, Q.M., Tomida, S., Takeuchi, T., Sugiyama, R., Itoh, Y., Yatabe, Y., Goto, H. and Takahashi, T. (2011) Proteasomal Non-Catalytic Subunit PSMD2 as a Potential Therapeutic Target in Association with Various Clinicopathologic Features in Lung Adenocarcinomas. Molecular Carcinogenesis, 50, 301-309. https://doi.org/10.1002/mc.20632
|
[15]
|
Zhao, H. and Lu, G. (2022) Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma. Frontiers in Genetics, 13, 905581. https://doi.org/10.3389/fgene.2022.905581
|
[16]
|
Li, Y., Huang, J., Zeng, B., Yang, D., Sun, J., Yin, X., Lu, M., Qiu, Z., Peng, W., Xiang, T., Li, H. and Ren, G. (2018) PSMD2 Regulates Breast Cancer Cell Proliferation and Cell Cycle Progression by Modulating P21 and P27 Proteasomal Degradation. Cancer Letters, 430, 109-122. https://doi.org/10.1016/j.canlet.2018.05.018
|
[17]
|
Ying, K., Wang, C., Liu, S., Kuang, Y., Tao, Q. and Hu, X. (2022) Diverse Ras-Related Gtpase DIRAS2, Downregulated by PSMD2 in A Proteasome-Mediated Way, Inhibits Colorectal Cancer Proliferation by Blocking NF-ΚB Signaling. International Journal of Biological Sciences, 18, 1039-1050. https://doi.org/10.7150/ijbs.68312
|
[18]
|
Gu, C., Wang, Y., Zhang, L., Qiao, L., Sun, S., Shao, M., Tang, X., Ding, P., Tang, C., Cao, Y., Zhou, Y., Guo, M., Wei, R., Li, N., Xiao, Y., Duan, J. and Yang, Y. (2022) AHSA1 Is A Promising Therapeutic Target For Cellular Proliferation and Proteasome Inhibitor Resistance in Multiple Myeloma. Journal of Experimental & Clinical Cancer Research, 41, 11. https://doi.org/10.1186/s13046-021-02220-1
|
[19]
|
崔珍珍. 蛋白酶体亚基PSMD2对HIV-1基因转录延伸调控的机制研究[D]: [硕士学位论文]. 厦门: 厦门大学, 2021.
|
[20]
|
熊秋宏, 李文静, 吴长新. 自噬和泛素-蛋白酶体系统之间的交联[J]. 中国生物化学与分子生物学报, 2018, 34(11): 1154-1159.
|
[21]
|
Xiong, Q., Fischer, S., Karow, M., MÜLler, R., Meßling, S. and Eichinger, L. (2018) ATG16 Mediates the Autophagic Degradation of the 19S Proteasomal Subunits PSMD1 and PSMD2. European Journal of Cell Biology, 97, 523-532. https://doi.org/10.1016/j.ejcb.2018.09.002
|